Table 1 Study participants been confirmed as having hepatitis B virus (HBV) or hepatitis C virus (HCV) infection according to 3 reference standards (RSs) and 3 study periods
Study | All participants | RS1 confirmed | RS2 confirmed | RS3 confirmed | ||||
|---|---|---|---|---|---|---|---|---|
Period (years) | No. | % | No. | % | No. | % | No. | % |
HBV | ||||||||
4 (2016–2019) | 10,000 | 100.0 | 146 | 1.5 | 247 | 2.5 | 537 | 5.4 |
8 (2012–2019) | 10,000 | 100.0 | 212 | 2.1 | 336 | 3.4 | 650 | 6.5 |
12 (2008–2019) | 10,000 | 100.0 | 297 | 3.0 | 394 | 3.9 | 729 | 7.3 |
HCV | ||||||||
4 (2016–2019) | 10,000 | 100.0 | 165 | 1.7 | 224 | 2.2 | 407 | 4.1 |
8 (2012–2019) | 10,000 | 100.0 | 336 | 3.4 | 375 | 3.8 | 498 | 5.0 |
12 (2008–2019) | 10,000 | 100.0 | 498 | 5.0 | 393 | 3.9 | 525 | 5.3 |